• 'I think both of us drew strength from it': qualitative reflections from next of kin following the death and post-mortem brain donation of a loved one with brain cancer
• A novel tetrahedral framework nucleic acid-derived chemodynamic therapy agent for effective glioblastoma treatment
• Advances in diffuse glioma assessment: preoperative and postoperative applications of chemical exchange saturation transfer
• Advancing cellular insights: Super-resolution STORM imaging of cytoskeletal structures in human stem and cancer cells
• Advancing glioblastoma treatment through iron metabolism: A focus on TfR1 and Ferroptosis innovations
• Advancing precision medicine in gliomas through single-cell sequencing: unveiling the complex tumor microenvironment
• Analysis of IDH and EGFR as biomarkers in glioblastoma multiforme: A case-control study
• Association between dichotomized VASARI feature and overall survival in glioblastoma patients: a single-institution propensity score matching analysis
• Astrocytes and the tumor microenvironment inflammatory state dictate the killing of glioblastoma cells by Smac mimetic compounds
• Boost Infiltration and Activity of T Cells via Inhibiting Ecto-5'-nucleotidase (CD73) Immune Checkpoint to Enhance Glioblastoma Immunotherapy
• Brazilian pediatric patients with gliomas: treatment characteristics and survival outcomes
• Combination chemotherapy via poloxamer 188 surface-modified PLGA nanoparticles that traverse the blood-brain-barrier in a glioblastoma model
• Comparing nnU-Net and deepflash2 for Histopathological Tumor Segmentation
• Comprehensive multimodal deep learning survival prediction enabled by a transformer architecture: A multicenter study in glioblastoma
• Conditioned Medium From Reactive Astrocytes Inhibits Proliferation, Resistance, and Migration of p53-Mutant Glioblastoma Spheroid Through GLI-1 Downregulation
• Contemporary Prognostic Signatures and Refined Risk Stratification of Gliomas: An Analysis of 4,400 Tumors
• Correction: AAA237, an SKP2 inhibitor, suppresses glioblastoma by inducing BNIP3-dependent autophagy through the mTOR pathway
• Corrigendum to: LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancement
• Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice
• Deep Learning Segmentation of Infiltrative and Enhancing Cellular Tumor on Pre- and Posttreatment Multishell Diffusion MRI of Glioblastoma
• Dendritic cell vaccine for glioblastoma: an updated meta-analysis and trial sequential analysis
• Directionally non-rotating electric field therapy delivered through implanted electrodes as a glioblastoma treatment platform: A proof-of-principle study
• Distinct tumor-TAM interactions in IDH-stratified glioma microenvironments unveiled by single-cell and spatial transcriptomics
• Distinguishing glioblastoma progression from treatment-related changes using DTI directionality growth analysis
• DRD4 promotes chemo-resistance and cancer stem cell-like phenotypes by mediating the activation of the Akt/β-catenin signaling axis in liver cancer
• Elucidating the pan-oncologic landscape of S100A9: prognostic and therapeutic corollaries from an integrative bioinformatics and Mendelian randomization analysis
• Enhancing cancer immunotherapy with mannose mimicking glycopolymer nanoparticles induced activation of Dendritic cells
• Ensemble learning-based pretreatment MRI radiomic model for distinguishing intracranial extraventricular ependymoma from glioblastoma multiforme
• Excessive lipid production shapes glioma tumor microenvironment
• Exploring the Trade-Off between generalist and specialized Models: A center-based comparative analysis for glioblastoma segmentation
• First independent validation of the proton-boron capture therapy concept
• FYN-mediated phosphorylation of BCKDK at Y151 promotes GBM proliferation by increasing the oncogenic metabolite N-acetyl-L-alanine
• Gastrodin Liposomes Block Crosstalk between Astrocytes and Glioma Cells via Downregulating Cx43 to Improve Antiglioblastoma Efficacy of Temozolomide
• Genomic, epigenomic and transcriptomic landscape of glioblastoma
• Glioblastoma concurrent with follicular lymphoma: A case report
• Glioma lateralization: Focus on the anatomical localization and the distribution of molecular alterations (Review)
• Histone Acetyl Transferase 1 Is Overexpressed in Poor Prognosis, High-grade Meningeal and Glial Brain Cancers: Immunohistochemical and Aptahistochemical Study
• Histopathological Spectrum of Gliomas and Its Immunohistochemical Correlation in a Tertiary Care Setup
• Human glioblastoma-derived cell membrane nanovesicles: a novel, cell-specific strategy for boron neutron capture therapy of brain tumors
• Hypoxia-driven heterogeneous expression of alpha5 integrin in glioblastoma stem cells is linked to HIF-2alpha
• Hypoxia-induced complement component 3 promotes aggressive tumor growth in the glioblastoma microenvironment
• Identifying and validating necroptosis-associated features to predict clinical outcome and immunotherapy response in patients with glioblastoma
• Inhibition of GPR68 kills glioblastoma in zebrafish xenograft models
• Inhibitory effects of Gracilaria edulis and Gracilaria salicornia against the MGMT and VEGFA biomarkers involved in the onset and advancement of glioblastoma using in silico and in vitro approaches
• Interleukin 4 and cancer resistance in glioblastoma multiforme
• Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis
• ITPKA phosphorylates PYCR1 and promotes the progression of glioma
• Lipid transfer from tumour-associated macrophages supports glioblastoma
• Living with glioblastoma - the need for integrated support based on experiences of chaos, loss of autonomy, and isolation in both patients and their relatives
• Losartan and Immune Checkpoint Inhibitors in Glioblastoma: An Appropriate Substitute for Steroids
• Mapping Tumor Habitats in IDH-Wild Type Glioblastoma: Integrating MR Imaging, Pathologic, and RNA Data from Ivy Glioblastoma Atlas Project
• Metabolic signatures derived from whole-brain MR-spectroscopy identify early tumor progression in high-grade gliomas using machine learning
• Molecular imaging with 68Ga-PSMA PET/CT in high grade glioma: A biomarker for tumour neo-angiogenesis
• Multiscale simulations reveal the driving forces of p53C phase separation accelerated by oncogenic mutations
• Naringin and temozolomide combination suppressed the growth of glioblastoma cells by promoting cell apoptosis: network pharmacology, in-vitro assays and metabolomics based study
• Navigating glioblastoma complexity: the interplay of neurotransmitters and chromatin
• Neutrophil-Targeting Semiconducting Polymer Nanotheranostics for NIR-II Fluorescence Imaging-Guided Photothermal-NO-Immunotherapy of Orthotopic Glioblastoma
• New insight into the CNC-bZIP member, NFE2L3, in human diseases
• NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation
• NUP37 promotes the proliferation and invasion of glioma cells through DNMT1-mediated methylation
• Oncogenic roles of long non-coding RNAs in essential glioblastoma signaling pathways
• Pan-cancer analysis identifies venous thromboembolism-related genes F3, PLAT, and C1S as potential prognostic biomarkers for glioblastoma and lower grade glioma
• Personalized optimization strategy for electrode array layout in TTFields of glioblastoma
• Predicting Survival in Glioblastoma Using Gene Expression Databases: A Neural Network Analysis
• Protein - carbohydrate interaction studies using domestic animals as role models support the search of new glycomimetic molecules
• Pulsed focused ultrasound alters the proteomic profile of the tumor microenvironment in a syngeneic mouse model of glioblastoma
• Pyrimidine compounds BY4003 and BY4008 inhibit glioblastoma cells growth via modulating JAK3/STAT3 signaling pathway
• Racial and social-economic inequalities in systemic chemotherapy use among adult glioblastoma patients following surgery and radiotherapy
• Radiomics Based Differentiation of Glioblastoma and Metastatic Disease: Impact of Different T1-Contrast Enhanced Sequences on Radiomic Features and Model Performance
• Radiosynthesis and preclinical evaluation of a (68)Ga-labeled tetrahydroisoquinoline-based ligand for PET imaging of C-X-C chemokine receptor type 4 in an animal model of glioblastoma
• Rapid phagosome isolation enables unbiased multiomic analysis of human microglial phagosomes
• Real-time estimation of the optimal coil placement in transcranial magnetic stimulation using multi-task deep learning
• Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome
• Research hotspots and trend of glioblastoma immunotherapy: a bibliometric and visual analysis
• Retraction notice to "Enhancement of resistance to chemo-radiation by hsa-miR-1290 expression in glioblastoma cells" [Eur. J. Pharmacol. 880 (2020) 173144]
• Ribosome stalling during <em>c-myc</em> translation presents actionable cancer cell vulnerability
• Role of long noncoding RNAs in the regulation of alternative splicing in glioblastoma
• SelK promotes glioblastoma cell proliferation by inhibiting beta-TrCP1 mediated ubiquitin-dependent degradation of CDK4
• Short-chain fatty acids reverses gut microbiota dysbiosis-promoted progression of glioblastoma by up-regulating M1 polarization in the tumor microenvironment
• Small Molecular Inhibitors That Target ATM for Drug Discovery: Current Research and Potential Prospective
• Spatial computational modelling illuminates the role of the tumour microenvironment for treating glioblastoma with immunotherapies
• Stepwise-targeting and hypoxia-responsive liposome AMVY@NPs carrying siYAP and verteporfin for glioblastoma therapy
• Strategies to overcome tumor microenvironment immunosuppressive effect on the functioning of CAR-T cells in high-grade glioma
• Targeting Glioblastoma: Efficacy of Ruthenium-Based Drugs
• Testing calpain inhibition in tumor endothelial cells: novel targetable biomarkers against glioblastoma malignancy
• The complex molecular epileptogenesis landscape of glioblastoma
• The Evaluation of Clinical Applications for the Detection of the Alzheimer's Disease Biomarker GFAP
• The infiltrative margins in glioblastoma: important is what has been left behind
• The role of NPC2 gene in glioma was investigated based on bioinformatics analysis
• The unfolded protein response sensor PERK mediates mechanical stress-induced maturation of focal adhesion complexes in glioblastoma cells
• Thymoquinone reversed doxorubicin resistance in U87 glioblastoma cells via targeting PI3K/Akt/mTOR signaling
• TiO(2)-ZnPc nanoparticles functionalized with folic acid as a target photosensitizer for photodynamic therapy against glioblastoma cells
• TP53 mutations and survival in patients with histologically defined Glioblastoma, IDH-wildtype
• Ultrasound-assisted water oxidation: unveiling the role of piezoelectric metal-oxide sonocatalysts for cancer treatment
• Unravelling the mosaic: Epigenetic diversity in glioblastoma
• Urinary D-asparagine level is decreased by the presence of glioblastoma
• Use of surface-modified porous silicon nanoparticles to deliver temozolomide with enhanced pharmacokinetic and therapeutic efficacy for intracranial glioblastoma in mice
• VEGFA contributes to tumor property of glioblastoma cells by promoting differentiation of myeloid-derived suppressor cells
• Velcrin molecular glues induce apoptosis in glioblastomas with high PDE3A and SLFN12 expression
• Venous Thromboembolism in Patients with Glioblastoma: Molecular Mechanisms and Clinical Implications